Search for: "Par Pharmaceutical"
Results 1 - 20
of 303
Sorted by Relevance
|
Sort by Date
9 May 2017, 9:59 pm
The decision arose out of a patent dispute between Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC,... [read post]
18 Apr 2019, 9:43 pm
Par Pharmaceutical Inc., District Judge Richard G. [read post]
21 Aug 2022, 9:11 pm
Eagle Pharmaceuticals, Inc. [read post]
16 Jul 2012, 7:56 am
TPG agreed on Monday to buy Par Pharmaceutical, a maker of generic drugs, in a $1.9 billion leveraged buyout, as merger activity in the health care industry continues to heat up. [read post]
16 Jul 2012, 7:56 am
TPG agreed on Monday to buy Par Pharmaceutical, a maker of generic drugs, in a $1.9 billion leveraged buyout, as merger activity in the health care industry continues to heat up. [read post]
16 Jul 2012, 7:56 am
TPG Capital has agreed to buy the generic drug maker Par Pharmaceutical in a $1.9 billion leveraged buyout, as merger activity in the health care industry continues to heat up. [read post]
3 Dec 2014, 9:59 pm
Noonan -- That it is more difficult today to be a patentee able to defend her patent rights than any time since the 1940's is nicely illustrated by the Federal Circuit's decision in Par Pharmaceutical, Inc. v. [read post]
2 Apr 2013, 2:48 pm
The post Par Pharmaceuticals Settles Civil and Criminal Off-Label Marketing Charges for $45 Million appeared first on Tycko & Zavareei LLP. [read post]
13 Sep 2012, 9:59 pm
Par Pharmaceutical, Inc., thereby allowing Santarus to keep Par's generic version of Zegerid® off the market until the expiration of the Orange Book-listed patents. [read post]
29 Nov 2020, 9:59 pm
This truism was the basis for the Federal Circuit affirming the District Court's decision against a generic drug producer in its recent decision in Par Pharmaceutical, Inc. v. [read post]
27 Jan 2014, 9:47 am
("Par Pharmaceutical Companies") and Par Pharmaceutical, Inc. [read post]
5 Apr 2013, 2:59 am
” The AP continues, “Officials from Woodcliff Lake-based Par Pharmaceutical Cos. entered the pleas Tuesday in federal court in Newark, N.J., and agreed to pay a total of $45 million in fines. [read post]
7 Sep 2011, 4:05 pm
A qui tam complaint against Par Pharmaceuticals was unsealed yesterday in Chicago. [read post]
2 Apr 2013, 1:55 pm
Last month, Par Pharmaceutical Companies Inc. pleaded guilty to federal criminal charges and agreed to settle civil allegations involving the company’s promotion of the drug Megace ES. [read post]
23 Jul 2007, 9:13 pm
By Sherri Oslick -- Ortho-McNeil, Inc. announced late last week that it has settled its lawsuit against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc. and Kali Laboratories, Inc., over the patent covering Ortho's Ultracet ® (tramadol hydrochloride and acetaminophen, used to treat acute pain). [read post]
18 Aug 2022, 11:39 am
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
18 Aug 2022, 11:39 am
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
16 Jul 2012, 1:24 pm
Some analysts believe that the TPG agreement undervalues Par Pharmaceutical, indicating that other suitors could surface. [read post]
7 Jun 2010, 9:59 pm
Par Pharmaceutical, Inc., the Federal Circuit exercised its prerogative to illustrate its fractured jurisprudence on two issues, obviousness and inequitable conduct, in a (fortunately) nonprecedential decision. [read post]
11 Sep 2012, 5:30 am
Par Pharmaceutical, Inc., which dealt with whether a drug covered by an Abbreviated New Drug Application (ANDA) infringed the patents owned by that patent owner relative to the proton pump inhibitors (PPI) product omeprazole. [read post]
